Cantor Fitzgerald Predicts Immunovant FY2025 Earnings
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Immunovant in a report issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal anticipates that the company will earn ($1.88) per share for the year. Cantor Fitzgerald has a “Strong-Buy” rating on the stock. The consensus estimate […]
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Immunovant in a report issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal anticipates that the company will earn ($1.88) per share for the year. Cantor Fitzgerald has a “Strong-Buy” rating on the stock. The consensus estimate […]
